Sociodemographic, mental health, and physical health factors associated with participation within re-contactable mental health cohorts: an investigation of the GLAD Study.
COPING study
GLAD Study
Participation bias
Re-contact
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
26 07 2023
26 07 2023
Historique:
received:
11
12
2022
accepted:
19
05
2023
medline:
28
7
2023
pubmed:
27
7
2023
entrez:
26
7
2023
Statut:
epublish
Résumé
The Genetic Links to Anxiety and Depression (GLAD) Study is a large cohort of individuals with lifetime anxiety and/or depression, designed to facilitate re-contact of participants for mental health research. At the start of the pandemic, participants from three cohorts, including the GLAD Study, were invited to join the COVID-19 Psychiatry and Neurological Genetics (COPING) study to monitor mental and neurological health. However, previous research suggests that participation in longitudinal studies follows a systematic, rather than random, process, which can ultimately bias results. Therefore, this study assessed participation biases following the re-contact of GLAD Study participants. In April 2020, all current GLAD Study participants (N = 36,770) were invited to the COPING study. Using logistic regression, we investigated whether sociodemographic, mental, and physical health characteristics were associated with participation in the COPING baseline survey (aim one). Subsequently, we used a zero-inflated negative binomial regression to examine whether these factors were also related to participation in the COPING follow-up surveys (aim two). For aim one, older age, female gender identity, non-binary or self-defined gender identities, having one or more physical health disorders, and providing a saliva kit for the GLAD Study were associated with an increased odds of completing the COPING baseline survey. In contrast, lower educational attainment, Asian or Asian British ethnic identity, Black or Black British ethnic identity, higher alcohol consumption at the GLAD sign-up survey, and current or ex-smoking were associated with a reduced odds. For aim two, older age, female gender, and saliva kit provision were associated with greater COPING follow-up survey completion. Lower educational attainment, higher alcohol consumption at the GLAD Study sign-up, ex-smoking, and self-reported attention deficit hyperactivity disorder had negative relationships. Participation biases surrounding sociodemographic and physical health characteristics were particularly evident when re-contacting the GLAD Study volunteers. Factors associated with participation may vary depending on study design. Researchers should examine the barriers and mechanisms underlying participation bias in order to combat these issues and address recruitment biases in future studies.
Sections du résumé
BACKGROUND
The Genetic Links to Anxiety and Depression (GLAD) Study is a large cohort of individuals with lifetime anxiety and/or depression, designed to facilitate re-contact of participants for mental health research. At the start of the pandemic, participants from three cohorts, including the GLAD Study, were invited to join the COVID-19 Psychiatry and Neurological Genetics (COPING) study to monitor mental and neurological health. However, previous research suggests that participation in longitudinal studies follows a systematic, rather than random, process, which can ultimately bias results. Therefore, this study assessed participation biases following the re-contact of GLAD Study participants.
METHODS
In April 2020, all current GLAD Study participants (N = 36,770) were invited to the COPING study. Using logistic regression, we investigated whether sociodemographic, mental, and physical health characteristics were associated with participation in the COPING baseline survey (aim one). Subsequently, we used a zero-inflated negative binomial regression to examine whether these factors were also related to participation in the COPING follow-up surveys (aim two).
RESULTS
For aim one, older age, female gender identity, non-binary or self-defined gender identities, having one or more physical health disorders, and providing a saliva kit for the GLAD Study were associated with an increased odds of completing the COPING baseline survey. In contrast, lower educational attainment, Asian or Asian British ethnic identity, Black or Black British ethnic identity, higher alcohol consumption at the GLAD sign-up survey, and current or ex-smoking were associated with a reduced odds. For aim two, older age, female gender, and saliva kit provision were associated with greater COPING follow-up survey completion. Lower educational attainment, higher alcohol consumption at the GLAD Study sign-up, ex-smoking, and self-reported attention deficit hyperactivity disorder had negative relationships.
CONCLUSIONS
Participation biases surrounding sociodemographic and physical health characteristics were particularly evident when re-contacting the GLAD Study volunteers. Factors associated with participation may vary depending on study design. Researchers should examine the barriers and mechanisms underlying participation bias in order to combat these issues and address recruitment biases in future studies.
Identifiants
pubmed: 37495971
doi: 10.1186/s12888-023-04890-x
pii: 10.1186/s12888-023-04890-x
pmc: PMC10373233
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
542Subventions
Organisme : Medical Research Council
Pays : United Kingdom
Informations de copyright
© 2023. The Author(s).
Références
J Epidemiol Community Health. 2010 Oct;64(10):874-84
pubmed: 19759057
Am J Epidemiol. 2000 Dec 1;152(11):1039-47
pubmed: 11117613
Epidemiol Psychiatr Sci. 2021 May 26;30:e45
pubmed: 34036933
BJPsych Open. 2020 Feb 06;6(2):e18
pubmed: 32026800
Soc Psychiatry Psychiatr Epidemiol. 2012 May;47(5):805-16
pubmed: 21544604
Nature. 2016 Oct 12;538(7624):161-164
pubmed: 27734877
Eur J Public Health. 2011 Jun;21(3):306-10
pubmed: 20570960
Lancet Psychiatry. 2020 Jul;7(7):567-568
pubmed: 32502467
JCPP Adv. 2021 Nov 10;1(3):e12043
pubmed: 37431437
BMC Public Health. 2013 Feb 23;13:167
pubmed: 23433250
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
J Cancer Surviv. 2019 Dec;13(6):829-839
pubmed: 31493162
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
J Aging Health. 2010 Apr;22(3):307-31
pubmed: 20103686
Int J Epidemiol. 2021 Mar 3;50(1):293-302
pubmed: 33057662
Compr Psychiatry. 2012 Jan;53(1):63-70
pubmed: 21397218
Public Health. 2015 Feb;129(2):162-72
pubmed: 25682575
Am J Epidemiol. 2010 Dec 1;172(11):1306-14
pubmed: 20843863
Compr Psychiatry. 2013 Nov;54(8):1131-9
pubmed: 23810078
BMC Med Res Methodol. 2012 Sep 24;12:148
pubmed: 23006680
Behav Res Ther. 2019 Dec;123:103503
pubmed: 31715324
Epidemiology. 2013 Jan;24(1):1-9
pubmed: 23211345
Am J Epidemiol. 2016 Jun 15;183(12):1149-58
pubmed: 27188935
J Thorac Dis. 2017 Jun;9(6):1725-1729
pubmed: 28740688
Eur Arch Psychiatry Clin Neurosci. 2022 Nov 24;:
pubmed: 36422680
Int J Epidemiol. 2018 Feb 1;47(1):226-235
pubmed: 29040562
Aust N Z J Public Health. 2006 Aug;30(4):353-61
pubmed: 16956166
Int J Epidemiol. 2018 Aug 1;47(4):1207-1216
pubmed: 29800128
Psychol Med. 2022 Jul 26;:1-14
pubmed: 35879886
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941